Puig S - Search Results

1

Prognostic implications of protein S-100beta serum levels in the clinical outcome of high-risk melanoma patients.

Domingo-Domènech J, Castel T, Auge JM, Garcia-Albeniz XA, Conill C, Puig S, Vilella R, Matas J, Malvehy J, Gascón P, Mellado B, Molina R. Domingo-Domènech J, et al. Among authors: puig s. Tumour Biol. 2007;28(5):264-72. doi: 10.1159/000110424. Epub 2007 Oct 26. Tumour Biol. 2007. PMID: 17962723

2

Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy: a two-step method.

Malvehy J, Puig S. Malvehy J, et al. Among authors: puig s. Clin Dermatol. 2002 May-Jun;20(3):297-304. doi: 10.1016/s0738-081x(02)00220-1. Clin Dermatol. 2002. PMID: 12074871 Review. No abstract available.

3

[Complete response of cerebral metastasic melanoma after a combined treatment of radiotherapy and temozolomide].

Conill C, Puig S, Toscas I, Castel T. Conill C, et al. Among authors: puig s. Med Clin (Barc). 2002 Nov 30;119(19):758-9. doi: 10.1016/s0025-7753(02)73570-7. Med Clin (Barc). 2002. PMID: 12487980 Spanish. No abstract available.

4

Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?

Vidal-Sicart S, Pons F, Puig S, Ortega M, Vilalta A, Martín F, Rull R, Palou JM, Castel T. Vidal-Sicart S, et al. Among authors: puig s. Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):362-6. doi: 10.1007/s00259-002-1051-7. Epub 2002 Dec 18. Eur J Nucl Med Mol Imaging. 2003. PMID: 12634963 Clinical Trial.

5

Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine.

Vilella R, Benitez D, Milà J, Vilalta A, Rull R, Cuellar F, Conill C, Vidal-Sicart S, Costa J, Yachi E, Palou J, Malvehy J, Puig S, Marti R, Mellado B, Castel T. Vilella R, et al. Among authors: puig s. Int J Cancer. 2003 Sep 10;106(4):626-631. doi: 10.1002/ijc.11242. Int J Cancer. 2003. PMID: 12845663

6

Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary?

Vidal-Sicart S, Pons F, Fuertes S, Vilalta A, Rull R, Puig S, Palou JM, Ortega M, Castel T. Vidal-Sicart S, et al. Among authors: puig s. Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):945-9. doi: 10.1007/s00259-004-1485-1. Epub 2004 Mar 3. Eur J Nucl Med Mol Imaging. 2004. PMID: 14997348 Clinical Trial.

7

[Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation].

Conill C, Fernández-Ibiza J, Malvehy J, Puig S, Sánchez M, Castel T. Conill C, et al. Among authors: puig s. Med Clin (Barc). 2004 Mar 27;122(11):413-5. doi: 10.1016/s0025-7753(04)74256-6. Med Clin (Barc). 2004. PMID: 15066248 Spanish.

8

Temozolomide as prophylaxis for melanoma brain metastases.

Conill C, González-Cao M, Jorcano S, Puig S, Malvehy J, Martí R, Castel T. Conill C, et al. Among authors: puig s. Melanoma Res. 2004 Feb;14(1):73-4. doi: 10.1097/00008390-200402000-00012. Melanoma Res. 2004. PMID: 15091198 Clinical Trial. No abstract available.

9

Dermoscopic patterns of benign volar melanocytic lesions in patients with atypical mole syndrome.

Malvehy J, Puig S. Malvehy J, et al. Among authors: puig s. Arch Dermatol. 2004 May;140(5):538-44. doi: 10.1001/archderm.140.5.538. Arch Dermatol. 2004. PMID: 15148097

10

Survivin expression in sentinel lymph nodes from melanoma patients.

González Cao M, Puig S, Mellado B. González Cao M, et al. Among authors: puig s. J Clin Oncol. 2004 Jul 1;22(13):2751-2; author reply 2752. doi: 10.1200/JCO.2004.99.313. J Clin Oncol. 2004. PMID: 15226347 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

997 results

Search Page

Filters